Business & Finance
BioSpecifics Technologies reports financial results for Q3 2018
12 November 2018 - BioSpecifics Technologies Corp (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a collagenase-based product mark...
BioArctic swings to profit in Q3 2018
9 November 2018 - BioArtic AB (STO:BIOAB), a research-based biopharmaceutical company, on Thursday reported profit of SEK25.9m, or EPS SEK0.29, for the third quarter 2018, from 1 July 2018 to 30 Septe...
Alligator Bioscience announces receipt of over USD3.5m in payments under partnership agreement with AbClon
8 November 2018 - Alligator Bioscience (Alligator) (STO:ATORX), a clinical-stage biotechnology company developing tumour-directed immuno-oncology antibody drugs, announced on Wednesday the receipt of ...
Bactiguard Holding widens loss in Q3 2018
7 November 2018 - Bactiguard Holding AB (Bactiguard)(STO:BACTIB), a Swedish medical device company, reported on Tuesday net loss of SEK0.5m, or SEK0.02 per share, for the third quarter of 2018, from J...
AstraZeneca divests rights of Alvesco, Omnaris and Zetonna to Covis Pharma
7 November 2018 - AstraZeneca plc (LSE:AZN), a global, science-led biopharmaceutical company, announced on Tuesday that it has entered into an agreement with Covis Pharma B.V (Covis Pharma), a special...
Vitrolife's net income up in Q3 2018
7 November 2018 - Medical device company Vitrolife AB (STO:VITR) on Tuesday reported net income of SEK75m, or EPS of SEK0.69, for the third quarter of 2018, from July 2018 to September 2018.This was a...